Table 2.

Visual outcomes of patients

	Best eye (SD)	Worse eye (SD)
Presentation	logMAR 0.14 (0.26)	logMAR 0.60 (0.73)
Start of biologic	logMAR 0.19 (0.34)	logMAR 0.52 (0.68)
Latest review	logMAR 0.16 (0.32)	logMAR 0.43 (0.72)	Mean: 4.46 years Median: 4.40 years
	Improve by ≥2 lines (%)	Retained vision (%)	Worsen by ≥2 lines (%)
Presentation to start of biologic (n=89)	17 eyes (19.1%)*	51 eyes (57.3%)*	21 eyes (23.6%)*
Start of biologic to latest review (n=89)	21 eyes (23.6%)*	63 eyes (70.8%)*	5 eyes (5.6%)*

*The proportion of patients on the improving, retaining or worsening vision is different between presentation to start of biologic and start of biologic to latest review (χ2=11.5, critical value=5.99).

logMAR, logarithm of the minimum angle of resolution.